Vivos Therapeutics, Inc. (VVOS) › Shareholders' EquityVivos Therapeutics, Inc. (VVOS) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: $4.83M2019: -$2.94M2020: $16.92M2021: $25.54M2022: $4.80M2023: $411.0K2024: $7.95M2025: -$1.49M-$1.49M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$1.49M-118.7%2024$7.95M+1835.3%2023$411.0K-91.4%2022$4.80M-81.2%2021$25.54M+51.0%2020$16.92M+674.8%2019-$2.94M-161.0%2018$4.83M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share